OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 23 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $781,000 | – | 43,736 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 357,960 | $5,173,000 | 4.54% |
| Granite Point Capital Management, L.P. | 75,000 | $1,084,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,874 | $1,444,000 | 0.11% |
| Eversept Partners, LP | 13,901 | $200,869 | 0.11% |
| BRASADA CAPITAL MANAGEMENT, LP | 20,400 | $295,000 | 0.10% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,197 | $350,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 24,373 | $352,000,000 | 0.01% |
| Spark Investment Management LLC | 12,835 | $185,000 | 0.01% |
| American Research & Management Co. | 300 | $4,000 | 0.00% |
| Advisor Group, Inc. | 4,700 | $69,000 | 0.00% |